kw.\*:("Prostate cancer")
Results 1 to 25 of 9845
Selection :
A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancerTAKAMIYA, Robert; WEINBERG, Vivian; YOUNG, C. Dale et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 4, pp 1073-1078, issn 0360-3016, 6 p.Conference Paper
Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: Feasibility and toxicityOH, William K; KAPLAN, Irving D; FEBBO, Philip et al.American journal of clinical oncology. 2003, Vol 26, Num 3, pp 312-316, issn 0277-3732, 5 p.Article
Definitive radiotherapy of prostate cancer: The possible role of staging lymphadenectomyFOSSA, Sophie D; LILLEBY, Wolfgang; WAEHRE, Hakon et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 33-41, issn 0360-3016, 9 p.Article
Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinomaROSSER, Charles J; REYES, Adriana O; VAKAR-LOPEZ, Funda et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 1, pp 1-6, issn 0360-3016, 6 p.Article
Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapySYMON, Zvi; GRIFFITH, Kent A; MCLAUGHLIN, P. William et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 2, pp 384-390, issn 0360-3016, 7 p.Article
Metafectene is superior to lipofectamine in the transfection of G5α prostate cancer cellsICZKOWSKI, Kenneth A; OMARA-OPYENE, A. Levi; KLÖSEL, Roland et al.Molecular biotechnology. 2004, Vol 28, Num 2, pp 97-103, issn 1073-6085, 7 p.Article
A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancerHOFFELT, S. Christopher; MARSHALL, Lynn M; GARZOTTO, Mark et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 29-32, issn 0360-3016, 4 p.Article
Urinary symptom flare following I-125 prostate brachytherapyCESARETTI, Jamie A; STONE, Nelson N; STOCK, Richard G et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 4, pp 1085-1092, issn 0360-3016, 8 p.Conference Paper
Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agentsFENG ZHANG; ARNATT, Christopher K; HANEY, Kendra M et al.European journal of medicinal chemistry. 2012, Vol 55, pp 395-408, issn 0223-5234, 14 p.Article
Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapyZELEFSKY, Michael J; YAMADA, Yoshiya; MARION, Christine et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 4, pp 956-963, issn 0360-3016, 8 p.Article
Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: Implications for treatment marginsLITTLE, Darren J; LEI DONG; LEVY, Lawrence B et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 5, pp 1218-1224, issn 0360-3016, 7 p.Article
What to do for prostate cancer patients with a rising PSA? A survey of australian practiceDUCHESNE, Gillian M; MILLAR, Jeremy L; MORAGA, Vladimir et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 4, pp 986-991, issn 0360-3016, 6 p.Article
Towards integrating functional imaging in the treatment of prostate cancer with radiation: The registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planningMIZOWAKI, Takashi; COHEN, Gil'Ad N; FUNG, Albert Y. C et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1558-1564, issn 0360-3016, 7 p.Article
Complexed PSA in routine diagnosisOREMEK, G. M; SAPOUTZIS, N; EDEN, F et al.Anticancer research. 2003, Vol 23, Num 2A, pp 975-977, issn 0250-7005, 3 p.Conference Paper
11C-acetate PET imaging of prostate cancer: Detection of recurrent disease at PSA relapse. CommentaryOYAMA, Nobuyuki; MILLER, Tom R; DIMITRAKOPOULOU-STRAUSS, Antonia et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 4, pp 549-558, issn 0161-5505, 10 p.Article
The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy ± neoadjuvant androgen deprivationPARKER, Chris; WARDE, Padraig; NORMAN, Andy et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 1, pp 53-58, issn 0360-3016, 6 p.Article
Impact of prolonged fraction delivery times on tumor control: A note of caution for Intensity-Modulated Radiation Therapy (IMRT)WANG, Jian Z; LI, X. Allen; D'SOUZA, Warren D et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 2, pp 543-552, issn 0360-3016, 10 p.Article
Rotational 3D-conformal radiation therapy (conformation therapy) combined with hormone therapy for the treatment of stage B2/C prostate cancer in Japanese menKARASAWA, Katsuyuki; KAIZU, Toshihide; NIIBE, Yuzuru et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 1, pp 208-212, issn 0360-3016, 5 p.Article
Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 GY)COZZARINI, Cesare; FIORINO, Claudio; CERESOLI, Giovanni Luca et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 3, pp 688-694, issn 0360-3016, 7 p.Article
Peut-on prevenir le cancer de la prostate: Rôle de la nutritionZLOTTA, A. R; EKANE, S; SCHULMAN, C. C et al.Louvain médical. 2003, Vol 122, Num 2, pp S25-S33, issn 0024-6956Article
Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 GY)RYU, Janice K; WINTER, Kathryn; COX, James D et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 4, pp 1036-1046, issn 0360-3016, 11 p.Article
Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlightBODIWALA, Dhaval; LUSCOMBE, Christopher J; LIU, Samson et al.Cancer letters. 2003, Vol 192, Num 2, pp 145-149, issn 0304-3835, 5 p.Article
p300 Modulates nuclear morphology in prostate cancerDEBES, Jose D; SEBO, Thomas J; HEEMERS, Hannelore V et al.Cancer research (Baltimore). 2005, Vol 65, Num 3, pp 708-712, issn 0008-5472, 5 p.Article
Evaluation of the houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time biasPICKLES, Tom; KIM-SING, Charmaine; MORRIS, W. James et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 1, pp 11-18, issn 0360-3016, 8 p.Article
High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicityYOSHIOKA, Yasuo; NOSE, Takayuki; YOSHIDA, Ken et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 1, pp 213-220, issn 0360-3016, 8 p.Article